These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 7750492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge.
    Linthorst AC, Flachskamm C, Hopkins SJ, Hoadley ME, Labeur MS, Holsboer F, Reul JM.
    J Neurosci; 1997 Jun 01; 17(11):4448-60. PubMed ID: 9151762
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
    Murakami N, Fukata J, Usui T, Naito Y, Tominaga T, Nakai Y, Masui Y, Nakao K, Imura H.
    J Pharmacol Exp Ther; 1992 Mar 01; 260(3):1344-8. PubMed ID: 1312168
    [Abstract] [Full Text] [Related]

  • 7. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 01; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 8. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov 01; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis.
    Schmidt ED, Janszen AW, Wouterlood FG, Tilders FJ.
    J Neurosci; 1995 Nov 01; 15(11):7417-26. PubMed ID: 7472494
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
    Maruyama H, Makino S, Noguchi T, Nishioka T, Hashimoto K.
    Neuroendocrinology; 2007 Nov 01; 86(1):1-16. PubMed ID: 17551262
    [Abstract] [Full Text] [Related]

  • 13. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J, Grino M, Bernet F, Dutriez-Casteloot I, Montel V, Dupouy JP.
    J Neuroendocrinol; 1998 May 01; 10(5):331-42. PubMed ID: 9663647
    [Abstract] [Full Text] [Related]

  • 14. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC, Johnson EO, Calogero AE, Kalogeras KT, Bernardini R, Chrousos GP, Gold PW.
    Endocrinology; 1992 Apr 01; 130(4):1764-74. PubMed ID: 1312423
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evidence suggesting that ghrelin O-acyl transferase inhibitor acts at the hypothalamus to inhibit hypothalamo-pituitary-adrenocortical axis function in the rat.
    Rucinski M, Ziolkowska A, Szyszka M, Hochol A, Malendowicz LK.
    Peptides; 2012 Jun 01; 35(2):149-59. PubMed ID: 22543218
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen.
    Muramami N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, Nakao K.
    Endocrinology; 1993 Dec 01; 133(6):2574-8. PubMed ID: 8243280
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C, Iyer V, Bhatnagar S.
    J Neuroendocrinol; 2007 Mar 01; 19(3):198-207. PubMed ID: 17280593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.